|
CBX3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.90030238609052E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.08690001232992E-09 |
| Normal-vs-Stage2 |
1.618240E-03 |
| Normal-vs-Stage3 |
2.17710000000038E-05 |
| Normal-vs-Stage4 |
1.80230053103969E-10 |
| Stage1-vs-Stage2 |
4.094400E-01 |
| Stage1-vs-Stage3 |
5.974200E-01 |
| Stage1-vs-Stage4 |
8.757400E-03 |
| Stage2-vs-Stage3 |
6.320400E-01 |
| Stage2-vs-Stage4 |
7.035600E-01 |
| Stage3-vs-Stage4 |
2.019200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.89720486385181E-11 |
| Normal-vs-AfricanAmerican |
4.812100E-04 |
| Normal-vs-Asian |
5.063700E-02 |
| Caucasian-vs-AfricanAmerican |
4.177600E-03 |
| Caucasian-vs-Asian |
3.778800E-01 |
| AfricanAmerican-vs-Asian |
1.924380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.60859991993334E-10 |
| Normal-vs-Female |
1.11950000381E-08 |
| Male-vs-Female |
3.766200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.476570E-03 |
| Normal-vs-Age(41-60Yrs) |
9.80699998986978E-09 |
| Normal-vs-Age(61-80Yrs) |
3.50300011220384E-10 |
| Normal-vs-Age(81-100Yrs) |
4.023900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.401000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.359200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.944500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.086200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.728270E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.338600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.399600E-02 |
| Normal-vs-Grade 2 |
1.13750000529933E-08 |
| Normal-vs-Grade 3 |
4.7020000115694E-09 |
| Normal-vs-Grade 4 |
1.51820000016123E-07 |
| Grade 1-vs-Grade 2 |
2.319600E-01 |
| Grade 1-vs-Grade 3 |
4.896600E-01 |
| Grade 1-vs-Grade 4 |
2.775600E-01 |
| Grade 2-vs-Grade 3 |
3.095200E-01 |
| Grade 2-vs-Grade 4 |
6.920200E-01 |
| Grade 3-vs-Grade 4 |
1.952200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.66830005365881E-09 |
| Normal-vs-ccB subtype |
8.08579999622694E-08 |
| ccA subtype-vs-ccB subtype |
9.632800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.40640002053306E-09 |
| Normal-vs-N1 |
5.116800E-03 |
| N0-vs-N1 |
1.592370E-01 |
|
|
